well it all depends on how well the trials go and what kind of deal they can strike for NV-07a.
I have a target price over $100 if Phenoxodiol works but it it works for multiple cancers this price could be quite conservative.
The NV-04 drug has the most potential but has the longest time till commercialisation.
In the mean time I think if you want to be exposed to developments then you just have to hold shares irrespective of what the charts say.
This is by far the most exciting period ever for the company, we'll know by the end of this year if Novogen's products will end up being a watershed event in the treatment of human disease.
Do some research on Soy Isoflavones and their benefits to heart, Cholesterol, cancer, menopause, prostate etc etc. You'll soon see how valuable Novogen's technological base is.
Cheers, Munch.
NRT Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
